| Product |
CAS |
Molecular formula |
More |
| 1-[2-Methoxy-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]- |
1092563-58-0 |
C18H29BN2O3 |
More |
| [2-Methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-pyr |
1092563-41-1 |
C18H26BNO3 |
More |
| 8-Bromo-2-(1-piperidin-4-yl-1h-pyrazol-4-yl)-quinoxaline |
1092500-75-8 |
C16H16BrN5 |
More |
| 8-Bromo-2-[4-(4-methyl-piperazin-1-yl)-phenyl]-quinoxaline |
1092500-73-6 |
C19H19BrN4 |
More |
| 8-Bromo-2-[6-(4-methyl-piperazin-1-yl)-pyridin-3-yl]-quinoxaline |
1092564-04-9 |
C18H18BrN5 |
More |
| 3-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyrazol-1-yl]-pipe |
1092563-74-0 |
C19H32BN3O4 |
More |
| 4-[5-Methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyrazol-1 |
1092563-67-1 |
C20H34BN3O4 |
More |
| 3-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyrazol-1-ylmethyl |
1092563-71-7 |
C20H34BN3O4 |
More |
| [4-(8-Bromo-quinoxalin-2-yl)-2-methyl-phenyl]-morpholin-4-yl-methanone |
1092563-91-1 |
C20H18BrN3O2 |
More |
| [4-(8-Bromo-quinoxalin-2-yl)-2-methyl-phenyl]-(4-methyl-piperazin-1-yl |
1092563-87-5 |
C21H21BrN4O |
More |
| 8-(4-Morpholin-4-ylmethyl-phenyl)-2-(3,4,5-trimethoxy-phenyl)-quinoxal |
1092499-10-9 |
C28H29N3O4 |
More |
| 5-Chlorosulfonyl-2-phenylindole |
1059628-90-8 |
C14H10ClNO2S |
More |
| 2-Phenyl-1h-indole-5-sulfonic acid |
27391-34-0 |
C14H11NO3S |
More |
| N-methoxy-n-methyl-3-aminosulfonylbenzamide |
889856-95-5 |
C9H12N2O4S |
More |
| (1-Aminocyclopentyl)acetic acid hydrochloride |
1049720-85-5 |
C7H13NO2.HCL |
More |
| (2H-tetrazol-5-ylmethyl)-carbamic acid tert-butyl ester |
115894-70-7 |
C7H13N5O2 |
More |
| Tert-butyl [2-(5-ethyl-2h-tetrazol-2-yl)ethyl]carbamate |
1056623-39-2 |
C10H19N5O2 |
More |
| Tert-butyl 2-(5-cyclopropyl-2h-tetrazol-2-yl)ethylcarbamate |
1056623-38-1 |
C11H19N5O2 |
More |
| 2-Chloro-n-phenyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-ben |
1106313-73-8 |
C18H21BClNO4S |
More |
| 4-(3-Iodo-1-isopropyl-1h-pyrazol-4-yl)-2-(methylsulfonyl)pyrimidine |
1111637-89-8 |
C11H13IN4O2S |
More |
